Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai

Parkinson's Disease Clinical Trial

— NQPDSH  

Official title:

Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04023201
• Other study ID #: XHEC-C-2019-094
• Status: Recruiting
• Start date: July 3, 2019
• Est. completion date: January 31, 2020

Study information

• Verified date: July 2019
• Source: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
• Contact: Yu Zhang
• Phone: 8613916006909
• Email: zhangyu0330[@]126.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a cross-sectional, retrospective clinical observation study focusing on the incidence and influencing factors of nocturnal symptoms in patients with Parkinson's disease.

Description:

This study was a cross-sectional, retrospective clinical observation study investigating the incidence and influencing factors of nocturnal symptoms in patients with Parkinson's disease through the Parkinson's disease sleep-related scale. At the same time, the effects of nocturnal symptoms on the quality of life of patients with Parkinson's disease were studied. About 1,500 Parkinson's patients will be recruited into the study who come from Shanghai, China.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1500
• Est. completion date: January 31, 2020
• Est. primary completion date: December 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

1. Parkinson's disease patients diagnosed according to the diagnostic criteria of MDS

2. Signing informed consent

Exclusion Criteria:

1. clinically suspected Parkinson's disease, has not been diagnosed;

2. suspected or diagnosed as secondary Parkinson's syndrome (vascular, drug, traumatic, encephalitis, toxic, etc.);

3. suspected or diagnosed as atypical Parkinson's syndrome (progressive supranuclear palsy, multiple system atrophy, cortical basal ganglia degeneration, etc.);

4. There is a clear history of stroke, moderate to severe traumatic brain injury, hydrocephalus, brain surgery or history of brain tumors;

5. severe cognitive impairment or psychiatric symptoms;

6. Can not cooperate with the completion of the study.

Related Conditions & MeSH terms

• Parkinson Disease
• Parkinson's Disease

Intervention

Other:
• Nocturnal symptoms
Parkinson's disease patients with or without nocturnal symptoms

Locations

Country	Name	City	State
China	Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine	Shanghai	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Country where clinical trial is conducted

China, 

References & Publications (1)

Grandas F, Iranzo A. Nocturnal problems occurring in Parkinson's disease. Neurology. 2004 Oct 26;63(8 Suppl 3):S8-11. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	nocturnal symptoms in patients with Parkinson's disease	the incidence and influencing factors of nocturnal symptoms in patients with Parkinson's disease	January 31, 2020